Fitness & Nutrition News
Discover the latest in fitness and nutrition with press releases highlighting trends, tips, and innovations in health and wellness. Stay informed on key developments influencing fitness routines and explore opportunities in nutrition science.
Jul 30, 2026 at 4:05 PM
Celsius Holdings to Release Second Quarter Results on Thursday, Aug. 6, 2026
BOCA RATON, Fla.--(BUSINESS WIRE)--Celsius Holdings will release its second quarter financial results before markets open on Thursday, Aug. 6, 2026....
Jul 30, 2026 at 9:10 AM
Sodexo's Clinicia Sets the Standard for the Future of Patient Nutrition
NORTH BETHESDA, Md.--(BUSINESS WIRE)--Sodexo today announced that Clinicia, its evidence-based patient nutrition program, is now helping 500 hospitals across the United States deliver 10 million personalized, clinically appropriate patient meals annually through 1,600 recipes, more than 80 therapeutic diets and the analysis of more than 175,000 menu data points each year – a reach that continues to grow. “Healthcare is redefining the role nutrition plays in patient care,” said Molly Matthews, C...
Jul 30, 2026 at 9:00 AM
OliX’s OLX501A Demonstrates Greater Visceral Fat Reduction Relative to a Global Comparator in Obese Non-Human Primates
SEOUL, South Korea--(BUSINESS WIRE)--New data highlight OLX501A’s potential to drive selective fat reduction, supporting its development as a next-generation RNAi-based obesity therapy....
Jul 30, 2026 at 7:00 AM
Verdiva Bio Initiates Phase 1 Study of VRB-103, a Selective Oral Amylin Peptide Analog With Weekly Dosing Potential
LONDON & SAN FRANCISCO--(BUSINESS WIRE)--Verdiva Bio Limited (“Verdiva Bio” or the “Company”), a clinical-stage biotechnology company advancing the development of a portfolio of once-weekly oral candidates for obesity and obesity-related disorders, today announces that the first patient has been dosed in a Phase 1 SAD study evaluating VRB-103, a once-weekly selective oral amylin analog, as a treatment for overweight and obesity. The Phase 1 randomized, double-blind, placebo-controlled study wil...
Jul 29, 2026 at 1:51 PM
Hims & Hers Responds to FTC Lawsuit
SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers Health, Inc. (NYSE: HIMS) responded to the lawsuit filed today by the Federal Trade Commission (FTC): This lawsuit disregards substantial evidence we provided the FTC during its nearly three-year investigation, ignores established state laws and industry standards in telehealth, and contorts the law to try to manufacture claims. This is not enforcement grounded in consumer protection; it is an effort to generate headlines at our expense. We are co...
Jul 29, 2026 at 7:30 AM
Aramark Correctional Services Reimagines Dining with Beyond the Tray, a First-of-Its-Kind Hospitality Program
PHILADELPHIA--(BUSINESS WIRE)--Aramark Correctional Services (ACS) announced today that it will launch Beyond the Tray with pilots in the Ohio and Indiana Departments of Correction this summer. The hospitality-driven dining program reimagines correctional dining, prioritizing dignity, consistency, and daily engagement. "Without compromising safety, we challenged ourselves to remove long-standing assumptions about correctional dining and build something better," said Tim Barttrum, President and...
Jul 29, 2026 at 6:45 AM
Kenvue Increases Quarterly Cash Dividend
SUMMIT, N.J.--(BUSINESS WIRE)--Kenvue Inc. (NYSE: KVUE) today announced that its Board of Directors declared a quarterly dividend of $0.21 per share on its common stock, which represents a 1.2 percent increase compared to the prior quarterly dividend. The quarterly dividend is payable on August 26, 2026, to shareholders of record as of the close of business on August 12, 2026. About Kenvue Kenvue Inc. is the world’s largest pure-play consumer health company by revenue. Built on more than a cent...
Jul 29, 2026 at 6:45 AM
OneSpaWorld Reports Second Quarter Fiscal 2026 Results
NASSAU, Bahamas--(BUSINESS WIRE)--OneSpaWorld Holdings Limited (NASDAQ: OSW) (“OneSpaWorld,” or the “Company”), the pre-eminent global provider of health, wellness and aesthetic services, products and experiences for guests on-board cruise ships and in destination resorts around the world, today announced its financial results for the second quarter and first six months of fiscal 2026 ended June 30, 2026. Leonard Fluxman, Executive Chairman and Chief Executive Officer, commented: “We are please...
Jul 28, 2026 at 4:10 PM
Phibro Animal Health Corporation Declares Quarterly Dividend
TEANECK, N.J.--(BUSINESS WIRE)--The Board of Directors of Phibro Animal Health Corporation (Nasdaq: PAHC) today declared a quarterly cash dividend of $0.12 per share on its Class A common stock and Class B common stock, , payable on September 23, 2026, to stockholders of record at the close of business on September 2, 2026.About Phibro Animal Health CorporationPhibro Animal Health Corporation is a leading global diversified animal health and nutrition company. We strive to be a trusted partner w...
Jul 28, 2026 at 12:00 PM
WHOOP Names Kyle Leahy Chief Commercial Officer to Scale Premium Distribution and Drive Growth
BOSTON--(BUSINESS WIRE)--WHOOP, the human performance company, today named Kyle Leahy Chief Commercial Officer. Leahy will lead the company’s commercial organization, overseeing global wholesale and retail, partnerships, enterprise, and healthcare go-to-market strategy.Leahy’s appointment comes as WHOOP expands with retailers and e-commerce marketplaces, grows its enterprise business, and builds relationships across healthcare in the United States and internationally.Leahy most recently served a...
Media & Journalist Tools
From headlines to storylines—Business Wire delivers the news you need, when you need it.